middl
east
respiratori
syndrom
coronaviru
merscov
infect
caus
acut
respiratori
ill
associ
high
case
fatal
rate
howev
pathogenesi
sever
fatal
merscov
infect
unknown
describ
histopatholog
immunohistochem
ultrastructur
find
first
autopsi
perform
fatal
case
merscov
world
relat
hospit
outbreak
unit
arab
emir
april
main
histopatholog
find
lung
diffus
alveolar
damag
evid
chronic
diseas
includ
sever
peripher
vascular
diseas
patchi
cardiac
fibrosi
hepat
steatosi
note
organ
doubl
stain
immunoassay
use
antiemerscov
antibodi
pair
immunohistochemistri
cytokeratin
surfact
identifi
pneumocyt
epitheli
syncyti
cell
import
target
merscov
antigen
doubl
immunostain
dipeptidyl
peptidas
show
coloc
scatter
pneumocyt
syncyti
cell
middl
east
respiratori
syndrom
coronaviru
merscov
initi
isol
sputum
specimen
patient
die
respiratori
renal
failur
saudi
arabia
recent
data
indic
dromedari
camel
like
transmit
merscov
human
humantohuman
merscov
transmiss
well
document
particularli
set
nosocomi
outbreak
juli
world
health
organ
notifi
laboratoryconfirm
case
merscov
infect
report
death
countri
primarili
men
median
age
year
case
report
kingdom
saudi
arabia
merscov
infect
result
wide
clinic
spectrum
asymptomat
infect
upper
respiratori
tract
ill
sever
pneumonia
multiorgan
failur
merscov
bind
dipeptidyl
support
cdc
oper
fund
find
conclus
report
author
necessarili
repres
offici
posit
cdc
disclosur
none
report
current
address
mgm
nation
cancer
instituteeshadi
grove
rockvil
md
peptidas
receptor
primarili
lower
respiratori
tract
also
distribut
tissu
although
numer
case
fatal
patholog
chang
viral
distribut
human
associ
sever
merscov
ill
unknown
knowledg
pathogenesi
remain
limit
report
provid
first
autopsi
clinicopatholog
immunohistochem
ihc
ultrastructur
descript
fatal
case
merscov
patient
multipl
close
contact
identifi
part
epidemiolog
investig
larg
cluster
merscov
infect
hospit
unit
arab
emir
uae
april
outbreak
occur
context
surg
case
arabian
peninsula
merscov
case
identifi
saudi
arabia
april
june
world
health
organ
http
mersen
last
access
octob
tissu
obtain
autopsi
fix
buffer
formalin
paraffinembed
section
mm
stain
routin
hematoxylin
eosin
immunostain
protocol
appli
use
sever
mous
antibodi
one
human
antibodi
merscov
describ
previous
ihc
assay
use
mous
antim
antibodi
tabl
lung
tissu
sampl
excis
paraffin
block
use
punch
process
electron
microscopi
examin
previous
describ
full
genom
sequenc
sanger
method
use
direct
genom
walk
pcr
nextgener
sequenc
illumina
miseq
illumina
san
diego
ca
perform
previous
describ
confirm
posit
lung
tissu
name
abu
deposit
genbank
http
wwwncbinlmnihgov
genbank
access
number
clustalw
use
align
full
genom
respect
avail
complet
near
complet
merscov
genom
american
journal
pathologyajpamjpatholorg
patient
nonsmok
obes
bodi
mass
index
kgm
filipino
man
relev
past
medic
histori
recent
travel
exposur
sick
contact
farm
anim
work
storag
room
paramed
station
patient
care
duti
share
hous
five
roommat
paramed
depart
present
emerg
depart
abu
dhabi
uae
april
histori
fever
rhinorrhea
product
cough
evalu
afebril
oxygen
satur
room
air
chest
xray
show
leftsid
opac
figur
patient
diagnos
acut
bronchiti
prescrib
mg
prednisolon
daili
day
paracetamol
discharg
return
emerg
depart
april
persist
cough
short
breath
chest
xray
show
leftsid
opac
air
bronchogram
patient
diagnos
pneumonia
given
prescript
levofloxacin
discharg
figur
return
emerg
depart
day
worsen
short
breath
admit
temperatur
c
puls
beat
per
minut
respiratori
rate
breath
per
minut
blood
pressur
oxygen
satur
room
air
left
basal
crackl
rale
arteri
blood
ga
room
air
show
ph
partial
pressur
carbon
dioxid
mm
hg
partial
pressur
oxygen
mm
hg
bicarbon
meql
consist
respiratori
alkalosi
laboratori
evalu
show
normal
white
blood
cell
count
lymphopenia
kml
creatinin
mgdl
supplement
tabl
blood
sputum
urin
cultur
obtain
nasopharyng
swab
specimen
sent
merscov
test
april
day
admiss
oseltamivir
ceftriaxon
azithromycin
start
empir
day
admiss
transfer
intens
care
unit
tachypnea
respiratori
distress
intub
mechan
ventil
portabl
chest
xray
show
multipl
patchi
airspac
opac
figur
patient
becam
hypotens
requir
inotrop
support
develop
acut
kidney
injuri
renal
failur
requir
dialysi
april
rtpcr
assay
nasopharyng
swab
specimen
collect
april
report
posit
merscov
upe
gene
target
bacteri
cultur
blood
sputum
urin
specimen
obtain
admiss
antibiot
administr
neg
april
given
mg
hydrocortison
intraven
everi
hour
start
nitric
oxid
ppm
patient
condit
continu
deterior
die
april
bodi
kept
refriger
c
autopsi
perform
day
death
notabl
find
includ
massiv
pleural
effus
l
substanti
pericardi
effus
ml
abdomin
effus
edemat
consolid
lung
gener
congest
predomin
pulmonari
histolog
pattern
exudativephas
diffus
alveolar
damag
denud
bronchiolar
epithelium
promin
hyalin
membran
alveolar
fibrin
deposit
type
pneumocyt
hyperplasia
rare
multinucl
syncyti
cell
alveolar
septa
involv
edema
lymphocyt
fewer
plasma
cell
neutrophil
macrophag
figur
aec
dispers
foci
necrot
debri
seen
subpleur
within
alveoli
viral
inclus
seen
moder
anthracosi
present
four
antibodi
section
trachea
bronchi
show
mildtomoder
lymphocyt
mucos
submucos
inflamm
neutrophil
plasma
cell
figur
occasion
cluster
noninvas
extracellular
candida
yeast
hypha
seen
septa
alveolar
space
overli
respiratori
epithelium
suggest
postmortem
overgrowth
bronchial
submucos
gland
focal
necrot
figur
immunostain
merscov
antigen
identifi
unremark
necrot
bronchial
submucos
gland
figur
multipl
doubl
immunostain
immunoassay
perform
assess
coloc
merscov
cell
label
cytokeratin
surfact
doubl
stain
cytokeratin
confirm
presenc
viral
antigen
within
pneumocyt
epitheli
syncyti
cell
wherea
doubl
stain
show
two
distinct
popul
coloc
merscov
macrophag
figur
b
surfact
doubl
stain
reveal
type
pneumocyt
syncyti
cell
intracytoplasm
viral
antigen
figur
antigen
detect
pneumocyt
syncyti
cell
mononuclear
leukocyt
vascular
endothelium
although
coloc
merscov
observ
scatter
pneumocyt
syncyti
cell
figur
electron
microscopi
show
infect
degener
pneumocyt
encas
hyalin
membran
compos
fibrin
basement
membran
figur
cluster
individu
predomin
spheric
nm
diamet
viral
particl
observ
membranebound
vesicl
figur
kidney
show
increas
global
sclerot
glomeruli
glomeruli
thicken
bowman
capsul
sever
atherosclerosi
hyalin
arteriolosclerosi
patchi
interstiti
inflamm
intratubular
proteinac
granular
cast
diminish
lymphoid
follicl
robust
interfollicular
prolifer
pleomorph
immunoblast
intermix
polymorph
popul
reactiv
lymphocyt
seen
multipl
lymph
node
spleen
also
contain
numer
immunoblast
reactiv
lymphocyt
bone
marrow
normocellular
matur
trilineag
hematopoiesi
leftshift
american
journal
pathologyajpamjpatholorg
granulopoiesi
heart
reveal
diffus
myocyt
hypertrophi
moder
coronari
atherosclerosi
patchi
fibrosi
moder
steatosi
scatter
calcif
mild
portal
tract
lobular
lymphocyt
inflamm
identifi
liver
section
cerebrum
cerebellum
unremark
merscov
ihc
neg
multipl
specimen
differ
organ
includ
kidney
liver
spleen
sever
lymph
node
bone
marrow
small
intestin
colon
overal
histolog
wellpreserv
although
section
brain
show
minimaltomild
autolysi
kidney
show
moder
autolysi
genom
sequenc
similar
known
merscov
cluster
close
camelderiv
merscov
strain
obtain
alhasa
saudi
arabia
suggest
recent
origin
camel
although
patient
known
camel
exposur
indic
phylogenet
tree
supplement
figur
sequenc
case
close
contact
cluster
close
clade
support
transmiss
link
case
report
provid
invalu
insight
first
descript
publish
literatur
clinicopatholog
ihc
ultrastructur
find
fatal
case
merscov
infect
histopatholog
pattern
observ
lung
diffus
alveolar
damag
merscov
ihc
doubl
stain
techniqu
show
viral
antigen
predominantli
local
type
pneumocyt
epitheli
syncyti
cell
although
pathogenesi
sever
fatal
merscov
infect
unknown
postmortem
find
provid
critic
insight
includ
evid
pneumocyt
import
target
suggest
direct
cytopath
effect
contribut
merscov
respiratori
symptom
ex
vivo
studi
examin
merscoveinfect
human
lung
tissu
found
evid
pneumocyt
damag
electron
microscopi
includ
detach
type
pneumocyt
membran
bleb
suggest
apoptosi
howev
ihc
stain
merscov
patchi
impli
caus
immun
dysfunct
may
relev
acut
renal
failur
commonli
observ
critic
ill
merscov
patient
merscov
rna
detect
urin
howev
evid
extrapulmonari
merscov
dissemin
observ
suggest
acut
renal
failur
patient
caus
direct
renal
infect
like
factor
hypoperfus
cytokin
dysregul
presenc
merscov
antigen
submucos
gland
provid
mechan
viru
enter
respiratori
secret
becom
transmiss
patholog
featur
merscov
share
similar
respiratori
ill
sever
acut
respiratori
syndrom
sar
cov
sever
report
evalu
fatal
case
sarscov
describ
diffus
alveolar
damag
variou
stage
characterist
featur
ihc
stain
sarscov
antigen
primarili
alveolar
epitheli
cell
syncyti
cell
may
also
seen
coronaviru
infect
includ
sarscov
paramyxoviru
infect
merscov
entri
mediat
express
throughout
lower
respiratori
tract
also
numer
organ
includ
kidney
doubl
stain
merscov
ihc
seen
pneumocyt
syncyti
cell
consist
identif
cell
target
merscov
infect
addit
ex
vivo
model
detect
merscov
antigen
bronchial
epitheli
cell
pneumocyt
endothelium
bronchiolar
epithelium
endothelium
pneumocyt
alveolar
macrophag
correl
find
contrast
function
receptor
sarscov
angiotensinconvert
enzym
similar
angiotensinconvert
enzym
broad
distribut
heavi
express
alveolar
epitheli
cell
enterocyt
endotheli
cell
although
evid
show
sarscov
also
infect
type
pneumocyt
sarscov
detect
sever
extrapulmonari
site
situ
hybrid
electron
microscopi
includ
circul
lymphocyt
lymphoid
tissu
renal
distal
tubul
small
intestin
mucosa
merscov
rna
detect
blood
wide
distribut
differ
tissu
extrapulmonari
dissemin
could
possibl
detect
evid
merscov
spread
outsid
respiratori
tract
pulmonari
find
consolid
diffus
alveolar
damag
pleural
effus
evid
bacteri
pneumonia
consist
clinic
featur
report
critic
ill
adult
merscov
infect
patholog
evid
sever
chronic
diseas
patient
includ
myocardi
fibrosi
atherosclerosi
hepat
steatosi
correl
report
individu
underli
comorbid
endstag
renal
diseas
diabet
mellitu
hypertens
cardiac
diseas
increas
risk
develop
sever
merscov
infect
impact
lowdos
oral
prednisolon
admiss
intraven
hydrocortison
clinic
cours
fatal
outcom
merscov
patient
unknown
follicular
deplet
lymph
node
consist
corticosteroid
use
note
bacteri
coinfect
identifi
hydrocortison
dose
mg
everi
hour
intens
care
unit
death
higher
recommend
refractori
septic
shock
surviv
sepsi
campaign
guidanc
patient
receiv
dose
systemat
review
highdos
corticosteroid
treatment
sarscov
report
evid
harm
without
surviv
benefit
patient
influenza
viru
infect
corticosteroid
treatment
associ
increas
mortal
although
studi
need
therefor
evid
avail
highdos
corticosteroid
treatment
merscov
pulmonari
diseas
avoid
current
clinic
manag
merscov
patient
base
support
care
complic
adher
recommend
infect
prevent
control
measur
cdc
http
wwwcdcgovcoronavirusmersinfectionpreventioncontrolhtml
last
access
octob
find
provid
invalu
unpreced
insight
histolog
chang
pathogenesi
viral
dissemin
merscov
human
studi
includ
addit
postmortem
examin
evalu
host
immun
respons
identif
site
viral
replic
necessari
strengthen
knowledg
pathogenesi
transmiss
pattern
effect
treatment
strategi
optim
clinic
manag
infect
control
practic
